Updated:
Hongem Investment
Hongsen Investment is a venture capital fund that strives to support and further the pharmaceutical industry. It focuses on growing biotech companies with a...
Hongem Investment
Hongsen Investment is a venture capital fund that strives to support and further the pharmaceutical industry. It focuses on growing biotech companies with a strong team, proven technology, and sound business model, along with companies that have clear arbitrage and exit plans. The firm maintains strong relationships and networks with global top-notch research institutions and private equity firms.
General information
Firm type
Private Equity
Year founded
2020
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Principals
Dr. Xu Ya Jun
Managing Partner
Benson Tsang
Managing Partner
Dr. Lo Yuk Lam
Partner
Michael Hui
Partner
Dr. Xu Ya Jun
Managing Partner
Mr. Benson Tsang
Managing Partner
Dr. Lo Yuk Lam
Partner
Mr. Michael Hui
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Hongem Investment?
Hongem Investment does not publicly disclose its investment team or principals. The firm's decision-making structure is not available from public sources, and no named individuals have been linked to the firm in credible media reports.
Does Hongem Investment participate in fund commitments or only direct deals?
Hongem Investment's investment approach includes direct investments and co-investments alongside other institutions. It does not publicly report any fund commitment activity as a limited partner.
Which sectors does Hongem Investment focus on?
Hongem Investment focuses on technology and innovation-driven sectors, including enterprise software, fintech, digital health, AI/ML, and climate tech. These areas align with broader growth trends in the Asian market.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: